CTLA4 and neoplasm: Next, functionally distinct subsets of these lymphocyte lineages based on specific phenotypes were analyzed and showed increased percentages of activated T cells in TILs, but similar percentages of regulatory T cells and similar expression levels of the co-inhibitory molecule CTLA-4 compared with splenocytes of tumor-bearing rats (Figure 1).